The differential role of extracellular signal-regulated kinases and p38 mitogen-activated protein kinase in eosinophil functions

T. Adachi, Barun Choudhury, S. Stafford, Sanjiv Sur, R. Alam

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

The activation of eosinophils by cytokines is a major event in the pathogenesis of allergic diseases. We have investigated the activation of mitogen-activated protein (MAP) kinases and their functional relevance in eosinophil differentiation, survival, degranulation, and cytokine production. IL-5 induced phosphorylation and activation of extracellular signal-regulated kinases (ERK) and p38 MAP kinases in eosinophils. PD98059, a MAP/ERK kinase inhibitor, blocked phosphorylation of ERK1/2 in a dose-dependent manner. SB202190, a p38 inhibitor, blocked p38-dependent phosphorylation of activating transcription factor-2. To study the importance of the MAP kinases on eosinophil differentiation, we cultured mouse bone marrow cells with IL-3 and IL-5 in the presence of the inhibitors. SB202190 dramatically inhibited eosinophil differentiation by 71%. PD98059 was less potent and reduced eosinophil differentiation by 28%. Both inhibitors marginally inhibited eosinophil survival only at the highest doses. Prolonged incubation of eosinophils with IL-5 induced significant eosinophil-derived neurotoxin release. Both PD98059 and SB202190 nearly completely inhibited (87% and 100% inhibition, respectively) IL-5-stimulated eosinophil-derived neurotoxin release in a dose-dependent manner. Next, we examined the effect of the MAP kinase inhibitors on eosinophil production of the cytokine macrophage- inflammatory protein (MIP)-1α. PD98059 blocked C5a- but not ionomycin- induced MIP-1α production (59% inhibition at 50 μM concentration). In contrast, SB202190 nearly completely inhibited (99%) C5a-induced MIP-1α production. Further, it blocked ionomycin-stimulated production by 66%. Our results suggest that both p38 and ERK1/2 MAP kinases play an important role in eosinophil differentiation, cytokine production, and degranulation. The p38 MAP kinase plays a greater role than ERK1/2 in eosinophil differentiation and cytokine production.

Original languageEnglish (US)
Pages (from-to)2198-2204
Number of pages7
JournalJournal of Immunology
Volume165
Issue number4
StatePublished - Aug 15 2000

Fingerprint

Extracellular Signal-Regulated MAP Kinases
p38 Mitogen-Activated Protein Kinases
Eosinophils
Interleukin-5
Macrophage Inflammatory Proteins
Cytokines
Eosinophil-Derived Neurotoxin
Mitogen-Activated Protein Kinases
Ionomycin
Phosphorylation
Activating Transcription Factor 2
Interleukin-3
Mitogen-Activated Protein Kinase 1
Protein Kinase Inhibitors
Mitogens
Bone Marrow Cells
Phosphotransferases

ASJC Scopus subject areas

  • Immunology

Cite this

The differential role of extracellular signal-regulated kinases and p38 mitogen-activated protein kinase in eosinophil functions. / Adachi, T.; Choudhury, Barun; Stafford, S.; Sur, Sanjiv; Alam, R.

In: Journal of Immunology, Vol. 165, No. 4, 15.08.2000, p. 2198-2204.

Research output: Contribution to journalArticle

Adachi, T. ; Choudhury, Barun ; Stafford, S. ; Sur, Sanjiv ; Alam, R. / The differential role of extracellular signal-regulated kinases and p38 mitogen-activated protein kinase in eosinophil functions. In: Journal of Immunology. 2000 ; Vol. 165, No. 4. pp. 2198-2204.
@article{44d8a6f717ec4d919dba8f28c47ab850,
title = "The differential role of extracellular signal-regulated kinases and p38 mitogen-activated protein kinase in eosinophil functions",
abstract = "The activation of eosinophils by cytokines is a major event in the pathogenesis of allergic diseases. We have investigated the activation of mitogen-activated protein (MAP) kinases and their functional relevance in eosinophil differentiation, survival, degranulation, and cytokine production. IL-5 induced phosphorylation and activation of extracellular signal-regulated kinases (ERK) and p38 MAP kinases in eosinophils. PD98059, a MAP/ERK kinase inhibitor, blocked phosphorylation of ERK1/2 in a dose-dependent manner. SB202190, a p38 inhibitor, blocked p38-dependent phosphorylation of activating transcription factor-2. To study the importance of the MAP kinases on eosinophil differentiation, we cultured mouse bone marrow cells with IL-3 and IL-5 in the presence of the inhibitors. SB202190 dramatically inhibited eosinophil differentiation by 71{\%}. PD98059 was less potent and reduced eosinophil differentiation by 28{\%}. Both inhibitors marginally inhibited eosinophil survival only at the highest doses. Prolonged incubation of eosinophils with IL-5 induced significant eosinophil-derived neurotoxin release. Both PD98059 and SB202190 nearly completely inhibited (87{\%} and 100{\%} inhibition, respectively) IL-5-stimulated eosinophil-derived neurotoxin release in a dose-dependent manner. Next, we examined the effect of the MAP kinase inhibitors on eosinophil production of the cytokine macrophage- inflammatory protein (MIP)-1α. PD98059 blocked C5a- but not ionomycin- induced MIP-1α production (59{\%} inhibition at 50 μM concentration). In contrast, SB202190 nearly completely inhibited (99{\%}) C5a-induced MIP-1α production. Further, it blocked ionomycin-stimulated production by 66{\%}. Our results suggest that both p38 and ERK1/2 MAP kinases play an important role in eosinophil differentiation, cytokine production, and degranulation. The p38 MAP kinase plays a greater role than ERK1/2 in eosinophil differentiation and cytokine production.",
author = "T. Adachi and Barun Choudhury and S. Stafford and Sanjiv Sur and R. Alam",
year = "2000",
month = "8",
day = "15",
language = "English (US)",
volume = "165",
pages = "2198--2204",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "4",

}

TY - JOUR

T1 - The differential role of extracellular signal-regulated kinases and p38 mitogen-activated protein kinase in eosinophil functions

AU - Adachi, T.

AU - Choudhury, Barun

AU - Stafford, S.

AU - Sur, Sanjiv

AU - Alam, R.

PY - 2000/8/15

Y1 - 2000/8/15

N2 - The activation of eosinophils by cytokines is a major event in the pathogenesis of allergic diseases. We have investigated the activation of mitogen-activated protein (MAP) kinases and their functional relevance in eosinophil differentiation, survival, degranulation, and cytokine production. IL-5 induced phosphorylation and activation of extracellular signal-regulated kinases (ERK) and p38 MAP kinases in eosinophils. PD98059, a MAP/ERK kinase inhibitor, blocked phosphorylation of ERK1/2 in a dose-dependent manner. SB202190, a p38 inhibitor, blocked p38-dependent phosphorylation of activating transcription factor-2. To study the importance of the MAP kinases on eosinophil differentiation, we cultured mouse bone marrow cells with IL-3 and IL-5 in the presence of the inhibitors. SB202190 dramatically inhibited eosinophil differentiation by 71%. PD98059 was less potent and reduced eosinophil differentiation by 28%. Both inhibitors marginally inhibited eosinophil survival only at the highest doses. Prolonged incubation of eosinophils with IL-5 induced significant eosinophil-derived neurotoxin release. Both PD98059 and SB202190 nearly completely inhibited (87% and 100% inhibition, respectively) IL-5-stimulated eosinophil-derived neurotoxin release in a dose-dependent manner. Next, we examined the effect of the MAP kinase inhibitors on eosinophil production of the cytokine macrophage- inflammatory protein (MIP)-1α. PD98059 blocked C5a- but not ionomycin- induced MIP-1α production (59% inhibition at 50 μM concentration). In contrast, SB202190 nearly completely inhibited (99%) C5a-induced MIP-1α production. Further, it blocked ionomycin-stimulated production by 66%. Our results suggest that both p38 and ERK1/2 MAP kinases play an important role in eosinophil differentiation, cytokine production, and degranulation. The p38 MAP kinase plays a greater role than ERK1/2 in eosinophil differentiation and cytokine production.

AB - The activation of eosinophils by cytokines is a major event in the pathogenesis of allergic diseases. We have investigated the activation of mitogen-activated protein (MAP) kinases and their functional relevance in eosinophil differentiation, survival, degranulation, and cytokine production. IL-5 induced phosphorylation and activation of extracellular signal-regulated kinases (ERK) and p38 MAP kinases in eosinophils. PD98059, a MAP/ERK kinase inhibitor, blocked phosphorylation of ERK1/2 in a dose-dependent manner. SB202190, a p38 inhibitor, blocked p38-dependent phosphorylation of activating transcription factor-2. To study the importance of the MAP kinases on eosinophil differentiation, we cultured mouse bone marrow cells with IL-3 and IL-5 in the presence of the inhibitors. SB202190 dramatically inhibited eosinophil differentiation by 71%. PD98059 was less potent and reduced eosinophil differentiation by 28%. Both inhibitors marginally inhibited eosinophil survival only at the highest doses. Prolonged incubation of eosinophils with IL-5 induced significant eosinophil-derived neurotoxin release. Both PD98059 and SB202190 nearly completely inhibited (87% and 100% inhibition, respectively) IL-5-stimulated eosinophil-derived neurotoxin release in a dose-dependent manner. Next, we examined the effect of the MAP kinase inhibitors on eosinophil production of the cytokine macrophage- inflammatory protein (MIP)-1α. PD98059 blocked C5a- but not ionomycin- induced MIP-1α production (59% inhibition at 50 μM concentration). In contrast, SB202190 nearly completely inhibited (99%) C5a-induced MIP-1α production. Further, it blocked ionomycin-stimulated production by 66%. Our results suggest that both p38 and ERK1/2 MAP kinases play an important role in eosinophil differentiation, cytokine production, and degranulation. The p38 MAP kinase plays a greater role than ERK1/2 in eosinophil differentiation and cytokine production.

UR - http://www.scopus.com/inward/record.url?scp=0034663903&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034663903&partnerID=8YFLogxK

M3 - Article

C2 - 10925307

AN - SCOPUS:0034663903

VL - 165

SP - 2198

EP - 2204

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 4

ER -